查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1806534

神经刺激设备市场按产品类型、材料类型、电源、技术、年龄层、应用、最终用户和分销管道划分 - 全球预测 2025-2030

Neurostimulation Device Market by Product Type, Material Type, Power Source, Technology, Age Group, Application, End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计神经刺激设备市场在 2024 年的价值将达到 66.2 亿美元，在 2025 年成长至 73.9 亿美元，复合年增长率为 11.89%，到 2030 年将达到 130 亿美元。

主要市场统计数据
基准年2024年 66.2亿美元
预计2025年 73.9亿美元
预测年份 2030 130亿美元
复合年增长率（%） 11.89%

在这个神经病变和感觉障碍困扰全球数百万人的时代，神经刺激设备应运而生，成为革命性的解决方案。这些技术将定向电脉衝传送至特定的神经通路，从而恢復功能或缓解慢性症状。从恢復听力的人工电子耳到改变帕金森氏症患者生活的深层脑部刺激器，神经刺激技术始终处于医学创新的前沿。

本执行摘要提炼了塑造神经刺激设备最重要的发展。它简洁而全面地概述了该行业的演变，重点介绍了推动应用的因素、製造商面临的挑战以及他们应该抓住的机会。包括设备开发商、医疗保健提供者、投资者和监管机构在内的相关人员可以发现新兴趋势、策略挑战和竞争格局。

本书整合了产业领先观点、监管文件和技术蓝图的洞见，为决策者提供应对复杂情况所需的知识。无论您对研发、打入市场策略或伙伴关係关係感兴趣，本书都能帮助您深入了解那些将定义神经刺激未来发展的主题。

了解神经刺激领域的变化：新兴技术进步、监管趋势和临床实践

过去十年，随着材料科学、设备小型化和数位整合技术的进步，神经刺激领域发生了显着变化。如今，植入式刺激器整合了闭合迴路回馈系统，可即时调整治疗方法，从而提高疗效并减少副作用。同时，电池技术的创新延长了设备的使用寿命，无线连接选项则允许透过云端对应平臺进行远端监控和个人化调整。

2025年美国关税政策对神经刺激设备供应链成本与竞争的累积影响分析

美国已于2025年实施新关税，对进口的金属生物材料、电子元件以及用于神经刺激设备的某些聚合物材料征收额外关税。製造商面临采购成本上升的局面，这种局面会波及整个供应链，迫使他们重新评估筹资策略以及与海外供应商的合约条款。因此，生产预算需要重新分配，以弥补增加的关税成本，这给产品价格和利润率带来了压力。

从神经刺激市场的产品材料、功率、使用年限、应用和最终用户维度获取关键细分洞察

深入研究细分领域，可以发现其在多个维度上呈现出微妙的成长轨迹。在评估产品类型时，人工电子耳在适应症不断扩展的推动下保持着强劲的研发管线，而脊髓刺激设备和迷走神经刺激设备在慢性疼痛和癫痫治疗中的应用正在加速。在材料领域，金属生物材料因其经过验证的生物相容性而继续占据主导地位，而聚合物替代品则因其灵活性和成本效益而日益普及。

揭示推动亚太地区神经刺激治疗领域成长机会和采用模式的关键区域动态

区域评估揭示了不同的成熟度曲线和采用模式。在美洲，美国凭藉高报销率和强劲的临床试验活动处于领先地位，而加拿大在其公共医疗框架内也表现出稳步的采用。拉丁美洲的成长情况参差不齐，受制于较小经济体的预算限制，以及都市区对先进医疗基础设施的投资。

了解塑造神经刺激技术和临床解决方案未来的关键参与者的策略性倡议和关键产品组合发展

竞争格局正由全球知名领导者和敏捷创新者塑造。大型医疗设备公司透过策略性收购专业新兴企业以及与科技公司合作，持续拓展其神经刺激产品组合。近期，一家电生理学先驱与数位健康公司合作，打造了一个封闭回路型刺激与远端分析结合的平台，旨在提升患者疗效并支持临床决策。

我们制定可行的策略建议，帮助产业领导者加速创新采用、优化营运并加强其市场定位。

产业领导者应优先投资新一代材料，以减少器械外形尺寸、提升病患舒适度，同时维持电气性能。与学术机构和合约研究组织建立研发合作伙伴关係，将加速概念验证研究，并释放新的适应症。企业也应透过签订双源协议和探索区域製造中心来实现供应来源多元化，以应对地缘政治和关税波动。

为神经刺激疗法开发全面的调查方法，包括资料收集方法和分析过程

本分析所采用的调查方法架构结合了定性和定量方法，以确保严谨性和可靠性。主要访谈对象包括神经科、生物医学工程师、供应链经理和付款人代表，旨在收集有关未满足临床需求、生产挑战和报销障碍的第一手资料。这些资料与来自监管备案文件、同行评审期刊和会议论文集的二手资料进行了整合。

综合策略见解并得出总体结论，以阐明神经刺激市场的现状和预测的未来发展轨迹

透过综合技术发展轨迹、监管趋势、市场细分和区域应用模式，本分析提供了对当前神经刺激生态系统的全面理解。关键要点强调了闭合迴路系统和先进生物材料在推动下一代设备性能、平衡新关税措施和供应链重组带来的营运需求方面的重要性。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 扩大监管核准加速创新神经刺激设备进入市场
  • 科技公司和医疗保健提供者合作改进神经刺激技术
  • 穿戴式神经刺激设备在慢性疼痛管理的应用日益增多
  • 神经刺激疗法对于忧郁症和焦虑症等精神疾病变得越来越重要。
  • 用于家庭治疗和长期使用的携带式神经刺激设备的开发
  • 非侵入性神经刺激技术的进步提高了患者的舒适度和治疗效果
  • 将人工智慧和机器学习融入神经刺激设备程式设计和个人化
  • 加强神经调节在神经退化性疾病治疗和復健的研究
  • 无线神经刺激设备的出现提高了患者的活动能力和依从性
  • 专注于具有成本效益的神经刺激设备，以提高其在新兴市场的可及性

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第 8 章神经刺激设备市场（依产品类型）

  • 人工电子耳
  • 深层脑部刺激器（DBS）
  • 荐骨神经刺激器（SNS）
  • 脊髓刺激设备（SCS）
  • 迷走神经刺激设备（VNS）

第九章神经刺激设备市场（依材料类型）

  • 金属生医材料
  • 聚合物生医材料

第 10 章神经刺激设备市场（按电源）

  • 非充电式神经刺激设备
  • 可充电神经刺激设备

第 11 章神经刺激设备市场（按技术）

  • 植入式神经刺激设备
  • 非植入式装置

第十二章神经刺激设备市场（依年龄层）

  • 成人
  • 老年人
  • 孩子们

第十三章神经刺激设备市场（按应用）

  • 胃肠道疾病
  • 听力损失
  • 神经系统疾病
    • 肌张力不全症
    • 癫痫
    • 自发性震颤
    • 帕金森氏症
  • 疼痛管理
    • 癌症痛
    • 慢性疼痛
  • 睡眠呼吸中止症
  • 尿失禁和大便失禁
    • 肠道疾病
    • 膀胱过动症

第 14 章神经刺激设备市场（按最终用户）

  • 门诊手术中心（ASC）
  • 家庭医疗保健
  • 医院
  • 专科诊所

第 15 章神经刺激设备市场（依通路）

  • 离线
  • 在线的

第 16 章：美洲神经刺激设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

17. 欧洲、中东和非洲神经刺激设备市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

第 18 章：亚太神经刺激设备市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十九章 竞争态势

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Abbott Laboratories
    • Bayer AG
    • Beijing PINS Medical Co.
    • Bioventus Inc.
    • Boston Scientific Corporation
    • Cefaly Technology
    • Curonix LLC.
    • electroCore Inc
    • InCube Labs.
    • Integra LifeSciences Holdings Corporation
    • LivaNova PLC
    • Medtronic PLC
    • MicroTransponder, Inc.
    • Motif Neurotech, Inc.
    • Neurosigma, Inc.
    • Nevro Corporation
    • SceneRay Co., Ltd
    • Soterix Medical, Inc.
    • Stimwave LLC
    • Synapse Biomedical Inc.

第20章 研究人工智慧

第21章 研究统计

第22章 研究联络人

第23章 研究报导

第24章 附录

Product Code: MRR-036C5CF3B4E1

The Neurostimulation Device Market was valued at USD 6.62 billion in 2024 and is projected to grow to USD 7.39 billion in 2025, with a CAGR of 11.89%, reaching USD 13.00 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 6.62 billion
Estimated Year [2025] USD 7.39 billion
Forecast Year [2030] USD 13.00 billion
CAGR (%) 11.89%

In an era where neurological disorders and sensory impairments affect millions worldwide, neurostimulation devices have emerged as a groundbreaking solution. These technologies deliver targeted electrical impulses to specific neural pathways, restoring function or alleviating chronic conditions. From cochlear implants that grant the gift of hearing to deep brain stimulators that transform the lives of patients with Parkinson's disease, neurostimulation stands at the cutting edge of medical innovation.

This executive summary distills the most critical developments shaping the landscape of neurostimulation devices. It provides a concise yet comprehensive overview of the industry's evolution, highlighting the forces driving adoption, the challenges confronting manufacturers, and the opportunities waiting to be seized. Stakeholders, including device developers, healthcare providers, investors, and regulatory authorities, will gain clarity on emerging trends, strategic imperatives, and the competitive landscape.

By synthesizing insights from leading industry voices, regulatory documents, and technological roadmaps, this document equips decision-makers with the knowledge required to navigate complexity. Whether your interest lies in research and development, market entry strategies, or partnership opportunities, this introduction sets the stage for a deeper exploration of the themes that will define the future of neurostimulation.

Understanding Transformational Shifts Reshaping the Neurostimulation Landscape: Emerging Technological Advances Regulatory Trends and Clinical Practices

Over the past decade, the neurostimulation landscape has been revolutionized by advances in materials science, device miniaturization, and digital integration. Implantable stimulators now incorporate closed-loop feedback systems that adapt therapy in real time, enhancing efficacy and reducing side effects. Concurrently, battery innovations have extended device longevity, while wireless connectivity options enable remote monitoring and personalized adjustments through cloud-enabled platforms.

Regulatory frameworks have evolved in tandem. Expedited review pathways and breakthrough device designations in the United States have accelerated approval times for novel therapies, while the European Union's Medical Device Regulation has raised the bar for clinical evidence and post-market surveillance. This regulatory convergence fosters greater global harmonization but also intensifies the demand for rigorous clinical validation and robust risk management.

Clinical practice guidelines are shifting as well. Physicians are increasingly adopting neuromodulation for off-label applications, driven by compelling real-world evidence. Reimbursement models have adapted to recognize the long-term cost savings associated with reduced medication use and hospital readmissions. Altogether, these transformational shifts are redefining the competitive imperatives for all stakeholders and creating new pathways for patient-centric innovation.

Analyzing the Cumulative Effects of 2025 United States Tariff Policies on Neurostimulation Device Supply Chains Costs and Competitive Positioning

The introduction of new tariff measures by the United States in 2025 has imposed additional duties on imported metallic biomaterials, electronic components, and certain polymeric supplies used in neurostimulation devices. Manufacturers face elevated procurement costs that cascade through the supply chain, prompting a reassessment of sourcing strategies and contract terms with overseas suppliers. As a result, production budgets have been reallocated to cover incremental tariff expenses, adding pressure on product pricing and profit margins.

In response, many firms have turned to nearshoring initiatives, relocating critical manufacturing steps to repatriated facilities within North America. This shift not only mitigates tariff burdens but also reduces logistical risks and lead times. To sustain cost competitiveness, device companies are engaging in proactive negotiations with strategic vendors and exploring alternative material formulations to hedge against duty fluctuations.

Despite these challenges, the industry has demonstrated resilience. Collaborative partnerships between raw material providers and device manufacturers have yielded joint cost-containment programs. Operational teams have optimized inventory management and streamlined customs processes. While the immediate impact manifested as temporary price adjustments, these collective efforts have laid the groundwork for a more agile and tariff-resilient supply chain moving forward.

Deriving Critical Segmentation Insights from Product Material Power Age Application and End User Dimensions in Neurostimulation Markets

A deep dive into the segmentation landscape reveals nuanced growth trajectories across multiple dimensions. When evaluating product type, cochlear implants maintain a robust pipeline driven by expanding indications, while spinal cord stimulators and vagus nerve stimulators show accelerated uptake in chronic pain and epilepsy management. Within the material realm, metallic biomaterials continue to dominate due to their proven biocompatibility, yet polymeric alternatives are gaining traction for their flexibility and cost efficiency.

Power source distinctions also shape market dynamics. Rechargeable neurostimulators are favored for their longevity and reduced need for surgical replacement, whereas non-rechargeable devices maintain stable demand in applications with limited power requirements. Implantable systems command a premium position, leveraging invasive techniques for targeted therapy, but non-implantable technologies are expanding access through wearable stimulators for conditions like sleep apnea.

Demographic factors further refine opportunity zones. Pediatric patients represent a specialized segment where device miniaturization and safety protocols are paramount, while geriatric populations drive demand in chronic pain and movement disorder treatments. In adult cohorts, applications span gastrointestinal disorders to urinary and fecal incontinence. Neurological disorder sub-segments such as dystonia, epilepsy, essential tremor, and Parkinson's disease present distinct clinical needs, as do pain management subdivisions focusing on cancer and chronic pain. End-user environments range from ambulatory surgery centers to home healthcare settings, with specialty clinics serving as centers of excellence. Offline channels remain the predominant route to market, though online platforms are emerging for post-market device support and remote programming services.

Unveiling Key Regional Dynamics Driving Growth Opportunities and Adoption Patterns across Americas EMEA and Asia Pacific Neurostimulation Sectors

Regional evaluation uncovers differing maturity curves and adoption patterns. In the Americas, the United States leads with high reimbursement rates and strong clinical trial activity, while Canada shows steady uptake under public healthcare frameworks. Latin America exhibits variable growth, propelled by urban centers that invest in advanced medical infrastructure, albeit tempered by budget constraints in smaller economies.

Within Europe, Middle East & Africa, Western European markets benefit from harmonized regulatory pathways and established neuromodulation programs, whereas Eastern European regions are gradually integrating advanced devices into public systems. The Middle East is characterized by government-funded healthcare initiatives that prioritize flagship hospitals, and Africa's market remains nascent, driven by select private facilities in urban hubs.

Asia-Pacific presents a dual narrative: Japan's well-funded research ecosystem and aging population fuel innovation and demand, while China's domestic players intensify competition through localized manufacturing and price-competitive offerings. In India and Southeast Asia, government investments in healthcare infrastructure and rising disposable incomes are unlocking new patient pools. Across these regions, digital health integration and telemedicine frameworks are rapidly evolving, facilitating remote patient monitoring and expanding the reach of neuromodulation therapies.

Illuminating Leading Strategic Moves and Portfolio Developments from Key Players Shaping the Future of Neurostimulation Technology and Clinical Solutions

The competitive landscape is shaped by established global leaders and agile innovators. Major medical device corporations continue to expand their neuromodulation portfolios through strategic acquisitions of specialist startups and partnerships with technology firms. Recent collaborations between electrophysiology pioneers and digital health companies have produced platforms that combine closed-loop stimulation with remote analytics, enhancing patient outcomes and clinical decision support.

Several players have advanced high-frequency stimulation modalities, targeting specific neuronal pathways with unprecedented precision. Others are developing next-generation electrode arrays with bioactive coatings to minimize fibrotic responses. Concurrently, emerging companies are introducing cost-effective non-implantable stimulators aimed at home-based applications, democratizing access for broader patient populations.

Leadership is increasingly defined by the ability to integrate multidisciplinary expertise-from neuroscience and materials engineering to software development and data analytics. Firms that demonstrate agility in navigating regulatory submissions, securing reimbursement coding, and scaling manufacturing will be best positioned to capitalize on the expanding neurostimulation market. Portfolio breadth, coupled with clinical evidence generation, remains the cornerstone of sustainable competitive advantage.

Formulating Actionable Strategic Recommendations to Help Industry Leaders Accelerate Innovation Adoption Optimize Operations and Strengthen Market Positioning

Industry leaders should prioritize investment in next-generation materials that reduce device profile and enhance patient comfort while maintaining electrical performance. Collaborative R&D alliances with academic institutions and contract research organizations will accelerate proof-of-concept studies and unlock novel indications. Companies must also diversify supply reservoirs by establishing dual-source agreements and exploring regional manufacturing hubs to buffer against geopolitical and tariff-related disruptions.

Engaging proactively with regulatory bodies can streamline approval processes; early dialogue regarding clinical trial design and risk-benefit analyses will mitigate uncertainties. Payers and providers should be engaged through value-based contracting models that align reimbursement with long-term patient outcomes. Training programs for surgeons and allied health professionals will support adoption of complex implantable systems, while digital literacy initiatives will increase patient acceptance of remote monitoring tools.

Finally, embracing data-driven service offerings-such as predictive maintenance of implantable devices and AI-powered therapy optimization-will create recurring revenue streams and strengthen customer loyalty. By executing these actionable recommendations, organizations can chart a course toward sustained innovation and commercial success in the evolving neurostimulation arena.

Articulating a Comprehensive Research Framework Including Methodological Approaches Data Collection Techniques and Analytical Processes for Neurostimulation

The research framework underpinning this analysis combines qualitative and quantitative methodologies to ensure rigor and reliability. Primary interviews were conducted with neurologists, biomedical engineers, supply chain directors, and payer representatives to gather firsthand perspectives on unmet clinical needs, manufacturing challenges, and reimbursement hurdles. These insights were triangulated with secondary data sourced from regulatory filings, peer-reviewed journals, and conference proceedings.

Material supply chain mapping employed trade data and customs records to identify key suppliers of metallic and polymeric biomaterials, while device shipment analytics highlighted regional distribution trends. Technology assessment drew upon patent landscape evaluations and product registries to track innovation trajectories in implantable and non-implantable devices. Clinical trial databases were mined to quantify study volumes across applications ranging from gastrointestinal disorders to movement disorders.

Analytical processes included scenario modeling to assess the impact of tariff adjustments and statistical clustering to uncover latent segmentation patterns. Data validation protocols were implemented through cross-referencing multiple independent sources, and an internal review board oversaw quality control measures. This comprehensive methodology ensures that the findings presented herein rest upon a robust evidentiary foundation, offering decision-makers a high degree of confidence in strategic planning and investment decisions.

Drawing Holistic Conclusions by Synthesizing Strategic Findings to Illuminate the Neurostimulation Market's Current State and Anticipated Future Trajectory

By synthesizing technological trajectories, regulatory developments, market segmentation, and regional adoption patterns, this analysis offers a holistic understanding of the current neurostimulation ecosystem. Key takeaways emphasize the importance of closed-loop systems and advanced biomaterials in driving next-generation device performance, balanced against the operational imperatives imposed by new tariff measures and supply chain realignments.

Segmentation insights highlight that cochlear implants and spinal cord stimulators will continue to anchor the market, even as emerging applications in gastrointestinal and urinary disorders unlock new growth corridors. Regional dynamics underscore the United States and Western Europe as early adopters, while Asia-Pacific and select Latin American markets present rapid expansion potential underpinned by healthcare investments and demographic shifts.

Competitive positioning will hinge on the ability to deliver clinically validated, patient-centric solutions at scale. Firms that effectively integrate cross-disciplinary expertise, leverage digital health platforms for remote care, and forge resilient supply networks will lead the charge. This conclusion sets the stage for executives to refine their strategic roadmaps and capitalize on the untapped opportunities across the multifaceted neurostimulation landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Expansion of regulatory approvals speeding up market entry for innovative neurostimulation devices
  • 5.2. Collaborations between tech companies and healthcare providers to improve neurostimulation technologies
  • 5.3. Rising adoption of wearable neurostimulation devices for chronic pain management
  • 5.4. Growing emphasis on neurostimulation solutions for mental health disorders like depression and anxiety
  • 5.5. Development of portable neurostimulation devices for home-based therapy and long-term use
  • 5.6. Advancements in non-invasive neurostimulation techniques enhancing patient comfort and outcomes
  • 5.7. Integration of AI and machine learning in neurostimulation device programming and personalization
  • 5.8. Increasing research on neuromodulation for neurodegenerative disease treatment and rehabilitation
  • 5.9. Emergence of wireless neurostimulation devices improving patient mobility and compliance
  • 5.10. Focus on cost-effective neurostimulation devices to enhance accessibility in emerging markets

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Neurostimulation Device Market, by Product Type

  • 8.1. Introduction
  • 8.2. Cochlear Implants
  • 8.3. Deep Brain Stimulators (DBS)
  • 8.4. Sacral Nerve Stimulators (SNS)
  • 8.5. Spinal Cord Stimulators (SCS)
  • 8.6. Vagus Nerve Stimulators (VNS)

9. Neurostimulation Device Market, by Material Type

  • 9.1. Introduction
  • 9.2. Metallic Biomaterials
  • 9.3. Polymeric Biomaterials

10. Neurostimulation Device Market, by Power Source

  • 10.1. Introduction
  • 10.2. Non-Rechargeable Neurostimulators
  • 10.3. Rechargeable Neurostimulators

11. Neurostimulation Device Market, by Technology

  • 11.1. Introduction
  • 11.2. Implantable Neurostimulation Devices
  • 11.3. Non-Implantable Devices

12. Neurostimulation Device Market, by Age Group

  • 12.1. Introduction
  • 12.2. Adult
  • 12.3. Geriatric
  • 12.4. Pediatric

13. Neurostimulation Device Market, by Application

  • 13.1. Introduction
  • 13.2. Gastrointestinal Disorders
  • 13.3. Hearing Loss
  • 13.4. Neurological Disorders
    • 13.4.1. Dystonia
    • 13.4.2. Epilepsy
    • 13.4.3. Essential Tremor
    • 13.4.4. Parkinson's Disease
  • 13.5. Pain Management
    • 13.5.1. Cancer Pain
    • 13.5.2. Chronic Pain
  • 13.6. Sleep Apnea
  • 13.7. Urinary & Fecal Incontinence
    • 13.7.1. Bowel Disorders
    • 13.7.2. Overactive Bladder

14. Neurostimulation Device Market, by End User

  • 14.1. Introduction
  • 14.2. Ambulatory Surgery Centers (ASCs)
  • 14.3. Home Healthcare
  • 14.4. Hospitals
  • 14.5. Specialty Clinics

15. Neurostimulation Device Market, by Distribution Channel

  • 15.1. Introduction
  • 15.2. Offline
  • 15.3. Online

16. Americas Neurostimulation Device Market

  • 16.1. Introduction
  • 16.2. United States
  • 16.3. Canada
  • 16.4. Mexico
  • 16.5. Brazil
  • 16.6. Argentina

17. Europe, Middle East & Africa Neurostimulation Device Market

  • 17.1. Introduction
  • 17.2. United Kingdom
  • 17.3. Germany
  • 17.4. France
  • 17.5. Russia
  • 17.6. Italy
  • 17.7. Spain
  • 17.8. United Arab Emirates
  • 17.9. Saudi Arabia
  • 17.10. South Africa
  • 17.11. Denmark
  • 17.12. Netherlands
  • 17.13. Qatar
  • 17.14. Finland
  • 17.15. Sweden
  • 17.16. Nigeria
  • 17.17. Egypt
  • 17.18. Turkey
  • 17.19. Israel
  • 17.20. Norway
  • 17.21. Poland
  • 17.22. Switzerland

18. Asia-Pacific Neurostimulation Device Market

  • 18.1. Introduction
  • 18.2. China
  • 18.3. India
  • 18.4. Japan
  • 18.5. Australia
  • 18.6. South Korea
  • 18.7. Indonesia
  • 18.8. Thailand
  • 18.9. Philippines
  • 18.10. Malaysia
  • 18.11. Singapore
  • 18.12. Vietnam
  • 18.13. Taiwan

19. Competitive Landscape

  • 19.1. Market Share Analysis, 2024
  • 19.2. FPNV Positioning Matrix, 2024
  • 19.3. Competitive Analysis
    • 19.3.1. Abbott Laboratories
    • 19.3.2. Bayer AG
    • 19.3.3. Beijing PINS Medical Co.
    • 19.3.4. Bioventus Inc.
    • 19.3.5. Boston Scientific Corporation
    • 19.3.6. Cefaly Technology
    • 19.3.7. Curonix LLC.
    • 19.3.8. electroCore Inc
    • 19.3.9. InCube Labs.
    • 19.3.10. Integra LifeSciences Holdings Corporation
    • 19.3.11. LivaNova PLC
    • 19.3.12. Medtronic PLC
    • 19.3.13. MicroTransponder, Inc.
    • 19.3.14. Motif Neurotech, Inc.
    • 19.3.15. Neurosigma, Inc.
    • 19.3.16. Nevro Corporation
    • 19.3.17. SceneRay Co., Ltd
    • 19.3.18. Soterix Medical, Inc.
    • 19.3.19. Stimwave LLC
    • 19.3.20. Synapse Biomedical Inc.

20. ResearchAI

21. ResearchStatistics

22. ResearchContacts

23. ResearchArticles

24. Appendix

LIST OF FIGURES

  • FIGURE 1. NEUROSTIMULATION DEVICE MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 18. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 20. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 24. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 27. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 28. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 29. NEUROSTIMULATION DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. NEUROSTIMULATION DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 31. NEUROSTIMULATION DEVICE MARKET: RESEARCHAI
  • FIGURE 32. NEUROSTIMULATION DEVICE MARKET: RESEARCHSTATISTICS
  • FIGURE 33. NEUROSTIMULATION DEVICE MARKET: RESEARCHCONTACTS
  • FIGURE 34. NEUROSTIMULATION DEVICE MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. NEUROSTIMULATION DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DEEP BRAIN STIMULATORS (DBS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DEEP BRAIN STIMULATORS (DBS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATORS (SNS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATORS (SNS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPINAL CORD STIMULATORS (SCS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPINAL CORD STIMULATORS (SCS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY VAGUS NERVE STIMULATORS (VNS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY VAGUS NERVE STIMULATORS (VNS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY METALLIC BIOMATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY METALLIC BIOMATERIALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POLYMERIC BIOMATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POLYMERIC BIOMATERIALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NON-RECHARGEABLE NEUROSTIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NON-RECHARGEABLE NEUROSTIMULATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY RECHARGEABLE NEUROSTIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY RECHARGEABLE NEUROSTIMULATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY IMPLANTABLE NEUROSTIMULATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY IMPLANTABLE NEUROSTIMULATION DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NON-IMPLANTABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NON-IMPLANTABLE DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HEARING LOSS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HEARING LOSS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DYSTONIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DYSTONIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ESSENTIAL TREMOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ESSENTIAL TREMOR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CANCER PAIN, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SLEEP APNEA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SLEEP APNEA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY BOWEL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY BOWEL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS (ASCS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS (ASCS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 109. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 111. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 113. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 115. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 117. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 119. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 121. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 129. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 130. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 131. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 133. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 135. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 136. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 137. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 138. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 139. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 140. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 141. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 143. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 144. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 145. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 146. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 147. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 149. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 151. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 152. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 153. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 154. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 155. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 157. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 159. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 160. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 161. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 162. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 163. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 164. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 165. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 167. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 168. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 169. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 171. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 173. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 174. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 175. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 176. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 177. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 179. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 181. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 182. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 183. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 184. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 185. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 186. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 187. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 189. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 191. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 193. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 195. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 196. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 197. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 198. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 199. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 201. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 203. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 204. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 205. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 206. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 207. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 208. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 209. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 211. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 212. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 213. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 215. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 217. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 218. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 219. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 221. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 223. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 225. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 226. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 227. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 228. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 229. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 230. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 231. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 233. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 259. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 261. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 263. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 265. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 267. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 269. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 272. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 274. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 281. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 283. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 285. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 286. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 287. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 288. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 289. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 291. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 293. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 294. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 295. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 296. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 297. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2024 (USD MILLION)
  • TABLE 298. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2025-2030 (USD MILLION)
  • TABLE 299. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 301. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 302. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 303. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 305. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 307. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2024 (USD MILLION)
  • TABLE 308. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025-2030 (USD MILLION)
  • TABLE 309. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 310. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 311. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 313. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 315. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 316. FRANCE NEUROSTIMULATION D